GPATCH2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.803600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.068600E-01
Normal-vs-Stage2
5.258800E-01
Normal-vs-Stage3
1.937810E-01
Normal-vs-Stage4
8.630300E-02
Stage1-vs-Stage2
8.122000E-01
Stage1-vs-Stage3
6.364200E-02
Stage1-vs-Stage4
9.881700E-02
Stage2-vs-Stage3
5.780500E-02
Stage2-vs-Stage4
7.396900E-03
Stage3-vs-Stage4
1.915740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.278600E-01
Normal-vs-AfricanAmerican
3.750400E-02
Normal-vs-Asian
4.764400E-01
Caucasian-vs-AfricanAmerican
9.986200E-02
Caucasian-vs-Asian
8.001400E-01
AfricanAmerican-vs-Asian
1.289180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.164600E-01
Normal-vs-Female
6.772600E-01
Male-vs-Female
1.026770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.989400E-01
Normal-vs-Age(41-60Yrs)
3.681000E-01
Normal-vs-Age(61-80Yrs)
6.987400E-01
Normal-vs-Age(81-100Yrs)
7.386400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.827800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.514000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.664600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.774000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.919950E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.643000E-01
Normal-vs-Daily Drinker
9.787400E-01
Normal-vs-Weekly Drinker
6.321000E-01
Normal-vs-Occasional Drinker
4.242000E-01
Normal-vs-Social Drinker
5.464200E-01
Non Drinker-vs-Daily Drinker
3.401600E-01
Non Drinker-vs-Weekly Drinker
9.159000E-01
Non Drinker-vs-Occasional Drinker
2.298000E-01
Non Drinker-vs-Social Drinker
9.699200E-01
Daily Drinker-vs-Weekly Drinker
3.776800E-01
Daily Drinker-vs-Occasional Drinker
8.027800E-02
Daily Drinker-vs-Social Drinker
3.561600E-01
Weekly Drinker-vs-Occasional Drinker
3.310600E-01
Weekly Drinker-vs-Social Drinker
9.423600E-01
Occasional Drinker-vs-Social Drinker
2.404400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.816000E-02
Normal-vs-Grade 2
2.315700E-02
Normal-vs-Grade 3
4.996800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.662490E-02
Grade 1-vs-Grade 3
4.743500E-03
Grade 1-vs-Grade 4
7.816000E-02
Grade 2-vs-Grade 3
6.664000E-01
Grade 2-vs-Grade 4
2.315700E-02
Grade 3-vs-Grade 4
4.996800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.348000E-01
Normal-vs-NonDiabetic
5.936800E-01
Diabetic-vs-NonDiabetic
1.472210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.704600E-01
Normal-vs-NoPancreatitis
6.852800E-01
Pancreatitis-vs-NoPancreatitis
5.770400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.320800E-01
Normal-vs-N1
5.743400E-01
N0-vs-N1
9.361600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.602400E-01
Normal-vs-TP53-NonMutant
7.817800E-01
TP53-Mutant-vs-TP53-NonMutant
1.062260E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
